Antiparasitic nitroimidazoles. IV. Serum protein binding and mode of action of 2-(4'-carboxystyryl)-5-nitro-1-vinylimidazole.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology*; D001798:Blood Proteins; D002247:Carbon Isotopes; D006224:Cricetinae; D004748:Entamoeba histolytica / Q000187:drug effects*; D006801:Humans; D007093:Imidazoles / Q000097:blood / Q000138:chemical synthesis / Q000494:pharmacology*; D051379:Mice; D009574:Nitro Compounds / Q000032:analysis / Q000097:blood / Q000138:chemical synthesis / Q000494:pharmacology; D011485:Protein Binding; D011817:Rabbits; D051381:Rats; D013056:Spectrophotometry, Ultraviolet; D014246:Trichomonas vaginalis / Q000187:drug effects*; D014345:Trypanosoma / Q000187:drug effects* / Q000201:enzymology
D000981:Antiprotozoal Agents; D001798:Blood Proteins; D002247:Carbon Isotopes; D007093:Imidazoles; D009574:Nitro Compounds; D000255:Adenosine Triphosphate